<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Medication is Not a Panacea</title>
	<atom:link href="http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/</link>
	<description>Rants and musings, without care for substance.</description>
	<pubDate>Thu, 08 Jan 2009 12:56:05 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
		<item>
		<title>By: Alex</title>
		<link>http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/#comment-1958</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Sat, 23 Jun 2007 15:26:15 +0000</pubDate>
		<guid isPermaLink="false">http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/#comment-1958</guid>
		<description>Dr. Dach: Among other reasons, part of the problem in measuring the effectiveness of a new compound (either in use or in testing) against depression is that the condition (for lack of a better word) affects everyone differently. There isn't a universally tangible condition we're trying to treat; unlike testing an antibacterial creme (where there's a physically measurable difference before and after application), a subjects vocal/written response to questions about their condition before/after medication/placebo is subjective at best.</description>
		<content:encoded><![CDATA[<p>Dr. Dach: Among other reasons, part of the problem in measuring the effectiveness of a new compound (either in use or in testing) against depression is that the condition (for lack of a better word) affects everyone differently. There isn&#8217;t a universally tangible condition we&#8217;re trying to treat; unlike testing an antibacterial creme (where there&#8217;s a physically measurable difference before and after application), a subjects vocal/written response to questions about their condition before/after medication/placebo is subjective at best.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jeffrey Dach</title>
		<link>http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/#comment-1854</link>
		<dc:creator>Jeffrey Dach</dc:creator>
		<pubDate>Sun, 17 Jun 2007 14:04:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.moundalexis.com/tm/2007/06/03/medication-is-not-a-panacea/#comment-1854</guid>
		<description>According to &lt;a href="http://psycinfo2.apa.org/doi/index.cfm?doi=10.1037/1522-3736.5.1.533r" rel="nofollow"&gt;Dr. Irving Kirsch in Prevention &#38; Treatment&lt;/a&gt;, “there is now unanimous agreement that the mean difference between response to SSRI antidepressant drugs and response to inert placebo is very small. It is so small that, despite sample sizes involving hundreds of participants, 57% of the SSRI trials funded by the pharmaceutical industry failed to show a significant difference between drug and placebo. Most of these negative data were not published and were accessible only by gaining access to US Food and Drug Administration (FDA) documents.

Various methods were used to manipulate the results of SSRI drug studies to insure a favorable outcome: 

1) Responders to the placebo are eliminated at the beginning of the study. (Placebo washout) 

2) Benzodiazepine sedatives were given to mask the SSRI induced agitation. 

3) Unfavorable drug studies are buried in the file cabinet and not disclosed to the public. 

4) Miscoding suicidal events as "emotional lability", and homicidal events as "aggression" to hide suicidal events from regulators. 

5) False attribution of suicide to the placebo arm. 

6) Hiring ghost writers to make the medical articles more favorable. 

7) Cash settlements for SSRI drug litigants which seals records and withholds unfavorable drug studies from the public.

For more information and links see my &lt;a href="http://jeffreydach.com/2007/05/14/paxil-prozac-and-ssri-induced-suicide-by-jeffrey-dach-md.aspx" rel="nofollow"&gt;Paxil, Prozac, and SSRI Induced Suicide Newsletter&lt;/a&gt;

&lt;a href="http://www.drdach.com/" rel="nofollow"&gt;Jeffrey Dach MD&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p>According to <a href="http://psycinfo2.apa.org/doi/index.cfm?doi=10.1037/1522-3736.5.1.533r" rel="nofollow">Dr. Irving Kirsch in Prevention &amp; Treatment</a>, “there is now unanimous agreement that the mean difference between response to SSRI antidepressant drugs and response to inert placebo is very small. It is so small that, despite sample sizes involving hundreds of participants, 57% of the SSRI trials funded by the pharmaceutical industry failed to show a significant difference between drug and placebo. Most of these negative data were not published and were accessible only by gaining access to US Food and Drug Administration (FDA) documents.</p>
<p>Various methods were used to manipulate the results of SSRI drug studies to insure a favorable outcome: </p>
<p>1) Responders to the placebo are eliminated at the beginning of the study. (Placebo washout) </p>
<p>2) Benzodiazepine sedatives were given to mask the SSRI induced agitation. </p>
<p>3) Unfavorable drug studies are buried in the file cabinet and not disclosed to the public. </p>
<p>4) Miscoding suicidal events as &#8220;emotional lability&#8221;, and homicidal events as &#8220;aggression&#8221; to hide suicidal events from regulators. </p>
<p>5) False attribution of suicide to the placebo arm. </p>
<p>6) Hiring ghost writers to make the medical articles more favorable. </p>
<p>7) Cash settlements for SSRI drug litigants which seals records and withholds unfavorable drug studies from the public.</p>
<p>For more information and links see my <a href="http://jeffreydach.com/2007/05/14/paxil-prozac-and-ssri-induced-suicide-by-jeffrey-dach-md.aspx" rel="nofollow">Paxil, Prozac, and SSRI Induced Suicide Newsletter</a></p>
<p><a href="http://www.drdach.com/" rel="nofollow">Jeffrey Dach MD</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
